Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 11,791 | 10,939 | 10,277 | 9,264 | 9,032 |
| Operating Income | -11,791 | -10,939 | -10,277 | -9,264 | -9,032 |
| Interest Expense | 475 | 486 | 375 | 161 | 181 |
| Other Income | 96 | 64 | -107 | 49 | 43 |
| Pre-tax Income | -12,170 | -11,361 | -10,759 | -9,376 | -9,170 |
| Net Income Continuous | -12,170 | -9,515 | -10,759 | -9,376 | -9,170 |
| Net Income | $-12,170 | $-9,515 | $-10,759 | $-9,376 | $-9,170 |
| EPS Basic Total Ops | -8.40 | -6.40 | -7.40 | -6.60 | -6.40 |
| EPS Basic Continuous Ops | -8.39 | -6.58 | -7.45 | -6.50 | -6.37 |
| EPS Diluted Total Ops | -8.40 | -6.40 | -7.40 | -6.60 | -6.40 |
| EPS Diluted Continuous Ops | -8.39 | -6.58 | -7.45 | -6.50 | -6.37 |
| EBITDA(a) | $-11,710 | $-10,857 | $-10,207 | $-9,209 | $-8,974 |